
Healthcare Global (HCG) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
5.8B
Gross Profit
3.0B
51.45%
Operating Income
476.5M
8.17%
Net Income
67.7M
1.16%
Balance Sheet Metrics
Total Assets
35.4B
Total Liabilities
25.5B
Shareholders Equity
9.9B
Debt to Equity
2.58
Cash Flow Metrics
Revenue & Profitability Trend
Healthcare Global Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 22.2B | 18.9B | 16.8B | 13.8B | 10.0B |
Cost of Goods Sold | 10.6B | 9.1B | 8.0B | 6.8B | 5.0B |
Gross Profit | 11.6B | 9.8B | 8.8B | 7.0B | 5.0B |
Gross Margin % | 52.1% | 51.9% | 52.3% | 50.7% | 50.2% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 1.1B | 1.0B | 604.9M | 412.0M |
Other Operating Expenses | 4.2B | 2.3B | 1.8B | 1.8B | 1.4B |
Total Operating Expenses | 4.2B | 3.4B | 2.8B | 2.4B | 1.9B |
Operating Income | 1.8B | 1.6B | 1.7B | 774.4M | -325.8M |
Operating Margin % | 7.9% | 8.3% | 9.9% | 5.6% | -3.2% |
Non-Operating Items | |||||
Interest Income | - | 127.0M | 118.1M | 115.6M | 156.1M |
Interest Expense | 1.5B | 994.5M | 914.7M | 838.9M | 1.1B |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 569.6M | 677.3M | 448.8M | 877.7M | -2.3B |
Income Tax | 81.3M | 264.0M | 272.5M | 488.5M | -75.6M |
Effective Tax Rate % | 14.3% | 39.0% | 60.7% | 55.7% | 0.0% |
Net Income | 488.3M | 413.3M | 176.3M | 389.2M | -2.2B |
Net Margin % | 2.2% | 2.2% | 1.1% | 2.8% | -22.0% |
Key Metrics | |||||
EBITDA | 4.2B | 3.4B | 3.3B | 2.4B | 1.2B |
EPS (Basic) | ₹3.19 | ₹3.46 | ₹2.11 | ₹4.14 | ₹-17.02 |
EPS (Diluted) | ₹3.14 | ₹3.43 | ₹2.10 | ₹3.97 | ₹-17.02 |
Basic Shares Outstanding | 139216301 | 139237131 | 139073790 | 129707612 | 113648953 |
Diluted Shares Outstanding | 139216301 | 139237131 | 139073790 | 129707612 | 113648953 |
Income Statement Trend
Healthcare Global Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 2.4B | 2.7B | 1.7B | 2.0B | 300.0M |
Short-term Investments | 1.2B | 372.4M | 292.3M | 66.4M | 1.4B |
Accounts Receivable | 4.0B | 2.9B | 3.0B | 2.2B | 1.9B |
Inventory | 530.2M | 426.7M | 382.9M | 299.7M | 211.1M |
Other Current Assets | 345.0M | 313.6M | 339.2M | 216.8M | 224.7M |
Total Current Assets | 8.4B | 6.8B | 5.8B | 5.0B | 4.3B |
Non-Current Assets | |||||
Property, Plant & Equipment | 19.6B | 673.5M | 533.6M | 435.6M | 400.4M |
Goodwill | 9.1B | 4.9B | 3.8B | 3.9B | 2.1B |
Intangible Assets | 489.1M | 466.9M | 187.0M | 298.0M | 214.9M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 404.8M | -240.0K | -251.0K | 331.1M | -10.0K |
Total Non-Current Assets | 27.0B | 20.3B | 17.4B | 17.2B | 16.0B |
Total Assets | 35.4B | 27.1B | 23.2B | 22.2B | 20.4B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 3.3B | 2.8B | 2.5B | 1.9B | 1.5B |
Short-term Debt | 4.6B | 2.3B | 864.0M | 859.0M | 1.6B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 367.0M | 39.8M | 755.1M | 785.0M | 626.2M |
Total Current Liabilities | 10.5B | 7.4B | 5.7B | 4.7B | 4.7B |
Non-Current Liabilities | |||||
Long-term Debt | 13.8B | 10.4B | 8.1B | 8.3B | 8.2B |
Deferred Tax Liabilities | 35.4M | 60.8M | 123.7M | 12.8M | 42.8M |
Other Non-Current Liabilities | 387.3M | 328.2M | 359.3M | 255.0M | 279.8M |
Total Non-Current Liabilities | 15.1B | 11.0B | 8.8B | 8.7B | 8.6B |
Total Liabilities | 25.5B | 18.4B | 14.5B | 13.4B | 13.2B |
Equity | |||||
Common Stock | 1.4B | 1.4B | 1.4B | 1.4B | 1.3B |
Retained Earnings | - | -5.0B | -4.5B | -4.4B | -4.8B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 9.9B | 8.7B | 8.7B | 8.8B | 7.1B |
Key Metrics | |||||
Total Debt | 18.4B | 12.7B | 9.0B | 9.1B | 9.8B |
Working Capital | -2.0B | -638.5M | 100.2M | 325.9M | -302.9M |
Balance Sheet Composition
Healthcare Global Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 569.6M | 677.3M | 448.8M | 877.7M | -2.3B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 65.4M | 78.5M | 65.1M | 31.0M | 19.1M |
Working Capital Changes | -1.1B | -396.9M | -1.0B | -575.0M | -590.0K |
Operating Cash Flow | 831.6M | 1.2B | 302.1M | 185.6M | -366.9M |
Investing Activities | |||||
Capital Expenditures | -2.1B | -1.8B | -1.3B | -704.4M | -353.6M |
Acquisitions | -2.0B | -450.0M | 0 | 379.9M | -52.5M |
Investment Purchases | -1.2B | -265.7M | -634.1M | -824.0M | 0 |
Investment Sales | 252.2M | 251.4M | 501.9M | 2.3B | - |
Investing Cash Flow | -5.0B | -2.3B | -1.4B | 1.1B | -1.8B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 2.2B | 2.9B | 554.3M | 1.7B | 140.6M |
Debt Repayment | -775.6M | -1.5B | -627.6M | -3.5B | -2.6B |
Financing Cash Flow | 1.4B | 986.3M | -55.4M | -860.6M | 2.3B |
Free Cash Flow | 1.1B | 989.0M | 1.2B | 1.5B | 851.0M |
Net Change in Cash | -2.7B | -155.6M | -1.1B | 433.9M | 148.2M |
Cash Flow Trend
Healthcare Global Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
249.65
Forward P/E
139.96
Price to Book
9.73
Price to Sales
3.90
PEG Ratio
139.96
Profitability Ratios
Profit Margin
1.61%
Operating Margin
8.14%
Return on Equity
4.49%
Return on Assets
1.25%
Financial Health
Current Ratio
0.81
Debt to Equity
185.57
Beta
-0.14
Per Share Data
EPS (TTM)
₹2.59
Book Value per Share
₹66.43
Revenue per Share
₹165.71
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
hcg | 90.1B | 249.65 | 9.73 | 4.49% | 1.61% | 185.57 |
Max Healthcare | 1.2T | 115.26 | 13.09 | 12.10% | 15.31% | 32.09 |
Apollo Hospitals | 1.0T | 72.09 | 12.70 | 18.85% | 6.63% | 90.89 |
Rainbow Children's | 149.1B | 58.14 | 10.16 | 16.50% | 16.73% | 51.77 |
Jupiter Life Line | 91.2B | 47.40 | 6.73 | 14.27% | 14.60% | 28.99 |
Kovai Medical Center | 68.2B | 32.68 | 6.28 | 19.24% | 15.42% | 38.24 |
Financial data is updated regularly. All figures are in the company's reporting currency.